Compare CREV & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CREV | SCNI |
|---|---|---|
| Founded | 2007 | 2003 |
| Country | Australia | Israel |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1M | 2.9M |
| IPO Year | N/A | N/A |
| Metric | CREV | SCNI |
|---|---|---|
| Price | $0.40 | $0.80 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 53.2K | ★ 60.4K |
| Earning Date | 01-30-2026 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | ★ $47,677,475.00 | $1,147,000.00 |
| Revenue This Year | $40.32 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.03 |
| Revenue Growth | 86.77 | ★ 303.87 |
| 52 Week Low | $0.36 | $0.61 |
| 52 Week High | $9.20 | $6.18 |
| Indicator | CREV | SCNI |
|---|---|---|
| Relative Strength Index (RSI) | 17.50 | 41.41 |
| Support Level | $1.58 | $0.75 |
| Resistance Level | $1.65 | $0.86 |
| Average True Range (ATR) | 0.11 | 0.09 |
| MACD | -0.09 | -0.02 |
| Stochastic Oscillator | 2.87 | 13.87 |
Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.